Virginia, 15 other states reach $86M settlement with opioid-dependence treatment company

The attorneys general claimed that Indivior violated federal law by marketing its products to physicians who were known to prescribe high volumes of opioids, and that the company failed to monitor suspicious orders for products, which led to them being inappropriately prescribed.

The settlement was led by the attorneys general of New York, Illinois, Tennessee, Utah, and Virginia, with help from an executive committee of attorneys general from other states.

"The opioid epidemic has ravaged Virginia families time and time again, with big pharmaceutical companies to blame in many cases. Indivior pushed buprenorphine-based products – which are used to treat opioid use disorder - to continue to line their own pockets," said Virginia Attorney General Jason Miyares. "It’s wrong to target those trying to recover, and I’m glad we were able to put a stop to it."

Funds from the settlement will be used for opioid addiction treatment, recovery, and prevention programs across the country.